Evidence map›Paper›PMID 35723488›Full record

ArticleJournal of visualized experiments : JoVE2022

An Optimized Single-Molecule Pull-Down Assay for Quantification of Protein Phosphorylation.

Elizabeth M Bailey, Emanuel Salazar-Cavazos, Rachel M Grattan, Michael J Wester, David J Schodt, Julian A Rojo, Keith A Lidke, Diane S Lidke

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elizabeth M BaileyDepartment of Pathology, University of New Mexico School of Medicine.
Emanuel Salazar-CavazosDepartment of Pathology, University of New Mexico School of Medicine.
Rachel M GrattanDepartment of Pathology, University of New Mexico School of Medicine.
Michael J WesterDepartment of Physics and Astronomy, University of New Mexico.
David J SchodtDepartment of Physics and Astronomy, University of New Mexico.
Julian A RojoDepartment of Pathology, University of New Mexico School of Medicine.
Keith A LidkeDepartment of Physics and Astronomy, University of New Mexico; Comprehensive Cancer Center, University of New Mexico Health Sciences Center.
Diane S LidkeDepartment of Pathology, University of New Mexico School of Medicine; Comprehensive Cancer Center, University of New Mexico Health Sciences Center; dlidke@salud.unm.edu.
University of New Mexico · USNew Mexico Cancer Center · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
University of New Mexico: MARC U*STAR Undergraduate Training ProgramT34GM008751 · NIGMS · UNIVERSITY OF NEW MEXICO · PI TAKACS-VESBACH, CRISTINA D. · 2000 to 2021
$6.0M
System Dynamics of PD-1 Signaling in T CellsR01AI153617 · NIAID · TRIAD NATIONAL SECURITY, LLC · PI William S Hlavacek, Diane Lidke · 2021 to 2026
$3.9M
Imaging the Early Events in Membrane Receptor SignalingR35GM126934 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Diane Lidke · 2018 to 2026
$3.1M
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responsesR01CA248166 · NCI · YALE UNIVERSITY · PI LEMMON, MARK A, LIDKE, DIANE · 2020 to 2024
$2.6M
NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA248166NIAID NIH HHS R01 AI153617NIGMS NIH HHS K12 GM088021NIGMS NIH HHS R35 GM126934NIGMS NIH HHS T34 GM008751
6 · The paper itself

Abstract

Phosphorylation is a necessary posttranslational modification that regulates protein function and directs cell signaling outcomes. Current methods to measure protein phosphorylation cannot preserve the heterogeneity in phosphorylation across individual proteins. The single-molecule pull-down (SiMPull) assay was developed to investigate the composition of macromolecular complexes via immunoprecipitation of proteins on a glass coverslip followed by single-molecule imaging. The current technique is an adaptation of SiMPull that provides robust quantification of the phosphorylation state of full-length membrane receptors at the single-molecule level. Imaging thousands of individual receptors in this way allows for quantifying protein phosphorylation patterns. The present protocol details the optimized SiMPull procedure, from sample preparation to imaging. Optimization of glass preparation and antibody fixation protocols further enhances data quality. The current protocol provides code for the single-molecule data analysis that calculates the fraction of receptors phosphorylated within a sample. While this work focuses on phosphorylation of the epidermal growth factor receptor (EGFR), the protocol can be generalized to other membrane receptors and cytosolic signaling molecules.

Indexed as

Single Molecule ImagingImmunoprecipitationMicroscopy, FluorescencePhosphorylationProtein Binding

Identifiers

PMID35723488
PMCPMC9317552
OpenAlexW4281721135

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.